RE-BVS – Piemonte Repository

Sfoglia per AUTORE
FERRERO B
Collezione ASL Asti

Items : 3

Long Term Follow-up of Rituximab for Anti-Myelin-Associated Glycoprotein Demyelinating Polyneuropathy in IgM Gammopathies: Clinical, Hematological and Neurophysiological Correlations in Blood

2024
ASL Torino 3
ASL Asti

Amaducci E; Dogliotti I; Vitale C; Schiavetti I; Clerico M; Benevolo G; Parisi M; Bertuzzo D; Peri V; Cavallo F; Ragaini S; Consoli C; Pironti M; Bruno B; Lopiano L; Di Liberto A; Drandi D; Ferrero B; Ferrero S;

Efficacy of rituximab in anti-myelin-associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2?years of follow-up. in European journal of neurology / Eur J Neurol. 2022 Dec;29(12):3611-3622. doi: 10.1111/ene.15553. Epub 2022 Sep 25.

2022
ASL Asti
ASL Città di Torino
AOU Città della Salute di Torino

Lopiano L; Ferrero B; Ferrero S; Drandi D; Artusi CA; Bondielli G; Ferrante M; Di Liberto A; Ragaini S; Cavallo F; Schiavetti I; Cavallo R; Benevolo G; Orsucci L; Dogliotti I; Clerico M; Parisi M; Bertuzzo D;

Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses in The Lancet

2022
ASL Asti

Pan H; Peto R; Hernández-García C; Røttingen J-A; Swaminathan S; Ryan M; Maggioni A; Babiker A; Cook D; Dondorp A; Kang G; Trelle S; McGinty S; Branca M; Appadoo S; Sauermann M; Sterne JAC; Rogers CA; Cappel-Porter H; Hutton D; Bellani S; Allum E; Kirwan J; Benassi V; Henao-Restrepo A-M; Lydon P; Miranda-Montoya MC; Preziosi M-P; Salami K; et alii...